hydrazine has been researched along with Amyotrophic Lateral Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Couvertier, S; Feyertag, F; Guckian, K; Huber, KVM; Johnson, DS; Martin, JG; Ward, JA; Zhang, L | 1 |
Cereda, C; Ceroni, M; Corato, M; Cova, E; Di Poto, C; Galli, A; Mazzini, G | 1 |
2 other study(ies) available for hydrazine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity.
Topics: Amyotrophic Lateral Sclerosis; Antineoplastic Agents; Cell Line, Tumor; Exportin 1 Protein; Glioblastoma; Humans; Hydrazines; Karyopherins; Receptors, Cytoplasmic and Nuclear; Triazoles | 2021 |
Effect of nitric oxide on lymphocytes from sporadic amyotrophic lateral sclerosis patients: toxic or protective role?
Topics: Amyotrophic Lateral Sclerosis; Analysis of Variance; Blotting, Western; Case-Control Studies; Humans; Hydrazines; Lymphocytes; Nitric Oxide; Nitric Oxide Donors; Proto-Oncogene Proteins c-bcl-2; Superoxide Dismutase; Superoxide Dismutase-1; Time Factors | 2006 |